Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Deep brain stimulation.

Sorin Breit1, Jörg B Schulz, Alim-Louis Benabid

  • 1Department of General Neurology, Hertie Institute for Clinical Brain Research, Center of Neurology, University of Tübingen, Hoppe-Seyler-Strasse 3, 72076 Tübingen, Germany. sorin.breit@uni-tuebingen.de

Cell and Tissue Research
|August 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal five-year follow-up by muscle MRI and high-resolution nerve ultrasound in hereditary neuropathies.

Neurological research and practice·2026
Same author

Transitional Life Events in Friedreich Ataxia: Differential Age at Onset Perspectives.

Cerebellum (London, England)·2026
Same author

Cerebellar cognitive-affective syndrome in Friedreich Ataxia.

Journal of neurology·2026
Same author

Magnetic Resonance Imaging of Nerve Roots in the Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - A Systematic Review and Meta-Analysis.

European journal of neurology·2026
Same author

Characterisation of patients with intracerebral haemorrhage with mixed location haemorrhages: clinical and imaging features, CSF neurodegeneration markers and recurrence risk.

European stroke journal·2026
Same author

A Patient-Reported Outcome Measure of Communication Difficulties in Friedreich Ataxia: COMATAX.

Cerebellum (London, England)·2026
Same journal

Correction to: Integrated morphological analyses of Cladomorphus phyllinus and transcriptomic analysis of Cladomorphus trimariensis provide insights into the cardiac morphophysiology of stick insects (Phasmida: Phasmatidae).

Cell and tissue research·2026
Same journal

Deletion of CEACAM1 does not affect retinal and choroidal morphology or transcriptome.

Cell and tissue research·2026
Same journal

Cardiac α2δ1 C-terminal contributes to left atrial hypertrophy in chronic ischemic heart failure, in association with changes in membrane GluN1 and p-CAMKII/p-HDAC4 signaling.

Cell and tissue research·2026
Same journal

Gill ionocytes of the Lake Magadi tilapia (Oreochromis Alcolapia grahami), an extremophilic teleost native to a highly alkaline environment.

Cell and tissue research·2026
Same journal

Integrated morphological analyses of Cladomorphus phyllinus and transcriptomic analysis of Cladomorphus trimariensis provide insights into the cardiac morphophysiology of stick insects (Phasmida: Phasmatidae).

Cell and tissue research·2026
Same journal

Effects of gestational protein restriction on autophagy dynamics during odontogenesis.

Cell and tissue research·2026
See all related articles

Deep brain stimulation (DBS) effectively treats Parkinson's disease (PD) by targeting the subthalamic nucleus (STN). While mechanisms are unclear, high-frequency stimulation offers significant motor improvements and reduces medication needs.

Area of Science:

  • Neuroscience
  • Neurosurgery
  • Neurology

Background:

  • Deep brain stimulation (DBS) is a standard treatment for advanced Parkinson's disease (PD), significantly improving motor function and quality of life.
  • The subthalamic nucleus (STN) is a primary target for DBS in PD due to its effectiveness in alleviating cardinal symptoms.
  • While clinically successful, the precise mechanisms underlying high-frequency DBS remain incompletely understood.

Purpose of the Study:

  • To review the current understanding of deep brain stimulation (DBS) for Parkinson's disease (PD).
  • To explore the theoretical basis and clinical efficacy of targeting the subthalamic nucleus (STN) for PD treatment.
  • To discuss the proposed mechanisms of action for high-frequency DBS and its potential neuroprotective effects.

Main Methods:

Related Experiment Videos

  • Review of existing experimental and clinical data on DBS for PD.
  • Analysis of the pathophysiology of basal ganglia in Parkinson's disease.
  • Examination of hypotheses regarding the mechanisms of high-frequency stimulation.

Main Results:

  • Subthalamic nucleus deep brain stimulation (STN-DBS) markedly improves motor symptoms and reduces levodopa dosage in PD patients.
  • High-frequency stimulation shares functional similarities with ablative procedures in brain structures.
  • Proposed mechanisms include depolarization blocking, information jamming, synaptic inhibition, and synaptic failure.

Conclusions:

  • STN-DBS is a highly effective therapy for advanced Parkinson's disease, improving motor function and reducing medication.
  • Understanding the mechanisms of high-frequency stimulation is crucial for optimizing DBS therapy.
  • STN-DBS may offer neuroprotective benefits by reducing glutamatergic drive, potentially slowing disease progression.